These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. US biotech policy issues remain in limbo. Fox JL Nat Biotechnol; 2001 Jun; 19(6):496-7. PubMed ID: 11385417 [No Abstract] [Full Text] [Related]
3. Regulation of biotechnology products in the global pharmaceutical market: the case of the European community and the United States. Hakim Z; Kucukarslan S Clin Ther; 1993; 15(2):442-58; discussion 432. PubMed ID: 8519050 [TBL] [Abstract][Full Text] [Related]
8. Agbiotech issues climb US political agenda. Fox JL Nat Biotechnol; 2002 Dec; 20(12):1179-80. PubMed ID: 12454658 [No Abstract] [Full Text] [Related]
9. US acts to lengthen term of patents to help biotechnology. Wadman M Nature; 1999 Aug; 400(6745):604. PubMed ID: 10458149 [No Abstract] [Full Text] [Related]
10. Surprise US election results may boost biotech. Fox JL Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655 [No Abstract] [Full Text] [Related]
11. US Patent Office strategic plan may penalize biotechs. Robertson D Nat Biotechnol; 2003 Apr; 21(4):345-6. PubMed ID: 12665807 [No Abstract] [Full Text] [Related]
12. US animal biotech regulations "may not be adequate". Fox JL Nat Biotechnol; 2002 Oct; 20(10):959. PubMed ID: 12355099 [No Abstract] [Full Text] [Related]
14. US policy may encourage counterfeit drugs. Bouchie A Nat Biotechnol; 2003 Feb; 21(2):121. PubMed ID: 12560826 [No Abstract] [Full Text] [Related]
15. The US biotechnology industry: an analysis of trends. Dibner MD Aust J Biotechnol; 1988 Sep; 2(2):129-32. PubMed ID: 2485326 [No Abstract] [Full Text] [Related]
16. The policy outlook from the Hill. Vastag B Nat Biotechnol; 2007 Jan; 25(1):13-6. PubMed ID: 17211381 [No Abstract] [Full Text] [Related]
17. Biotechnology and the future of humanity. Cameron NM J Contemp Health Law Policy; 2006; 22(2):413-23. PubMed ID: 17117704 [No Abstract] [Full Text] [Related]
18. US FTC probes practices of 100 companies. Robertson D Nat Biotechnol; 2001 Jun; 19(6):497-8. PubMed ID: 11385418 [No Abstract] [Full Text] [Related]
19. US biotechnology companies and foreign nationals: the changing dynamics of access to H-1B visas. Dahms AS; Trow SC Nat Biotechnol; 2005 May; 23(5):629-30. PubMed ID: 15877077 [No Abstract] [Full Text] [Related]
20. The 1992 biotechnology agenda: a message for candidates Bush and Clinton. Duzan SA Healthspan; 1992 Sep; 9(8):12-5. PubMed ID: 10122052 [No Abstract] [Full Text] [Related] [Next] [New Search]